Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (2) , 153-158
- https://doi.org/10.1016/0026-0495(89)90255-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.Journal of Clinical Investigation, 1984
- Ultracentrifugal subfractionation of high-density lipoproteinThe Analyst, 1984
- Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjectsAtherosclerosis, 1982
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia Chemical and physical propertiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Radioiodination of human low density lipoprotein: A comparison of four methodsClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in ManScience, 1974
- The metabolism of low density lipoprotein in familial type II hyperlipoproteinemiaJournal of Clinical Investigation, 1972
- Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patientJournal of Clinical Investigation, 1968
- The Theory of Tracer Experiments with 131I-Labelled Plasma ProteinsPhysics in Medicine & Biology, 1957